Brexit Finally Here But Uncertainty Not Over For Biopharma
Doubts Persist On Regulatory Alignment And Migration
Executive Summary
A free trade deal needs to be negotiated in record time and UK life sciences must face up to diverging from the EU.
You may also be interested in...
Moderna Takes The Lead With Plan To Tackle New COVID-19 Variants
Moderna has unveiled plans to develop a new booster vaccine, tweaked to meet the threat posed by the South African strain.
Servier and MiNA Target Neurodegenerative Disease With Novel RNA Therapy
Already partnering with AZ and Boehringer Ingelheim in liver targets, the UK biotech sees potential to hit ‘undruggable’ CNS targets as well.
Lung Cancer Failure Isn't The End For Merck KGaA And GSK's Bintrafusp
Key cancer asset is still looking for a Phase III validation after failing to outperform Keytruda in challenging frontline NSCLC setting.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports